Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Retroviral Agent”

Showing 20 of 0 results

Not applicableWithdrawnNCT00006578
What this trial is testing

Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00002190
What this trial is testing

A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 30
Post-approval studies (Phase 4)Study completedNCT00055120
What this trial is testing

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Who this might be right for
HIV InfectionsAIDS-Related Opportunistic Infections
National Institute of Allergy and Infectious Diseases (NIAID) 283
Not applicableStudy completedNCT00000945
What this trial is testing

Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients

Who this might be right for
HIV InfectionsLeukoencephalopathy, Progressive Multifocal
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)UnknownNCT00002396
What this trial is testing

The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients

Who this might be right for
HIV Infections
Gilead Sciences 60
Large-scale testing (Phase 3)Study completedNCT00002368
What this trial is testing

The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Boehringer Ingelheim 2,000
Large-scale testing (Phase 3)Study completedNCT00002391
What this trial is testing

The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome
Large-scale testing (Phase 3)Study completedNCT00002450
What this trial is testing

Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients

Who this might be right for
HIV Infections
Gilead Sciences 600
Early research (Phase 1)Study completedNCT00000864
What this trial is testing

Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)Study completedNCT04109183
What this trial is testing

A Drug Safety and Dose-exploratory Clinical Study of Azvudine Tablets in Patients Who Have Not Received Anti-HIV Treatment

Who this might be right for
AIDS
Henan Genuine Biotech Co., Ltd. 172
Testing effectiveness (Phase 2)Study completedNCT00011011
What this trial is testing

Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 94
Not applicableStudy completedNCT00051805
What this trial is testing

Promoting Adherence to Anti-HIV Drug Regimens

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 119
Testing effectiveness (Phase 2)Study completedNCT00002364
What this trial is testing

1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome 40
Testing effectiveness (Phase 2)Study completedNCT00001086
What this trial is testing

Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Large-scale testing (Phase 3)Study completedNCT00039741
What this trial is testing

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 266
Not applicableStudy completedNCT00000859
What this trial is testing

Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,300
Not applicableEnded earlyNCT00000875
What this trial is testing

Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 16
Testing effectiveness (Phase 2)Study completedNCT00038272
What this trial is testing

DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Large-scale testing (Phase 3)Study completedNCT00002367
What this trial is testing

Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Hoffmann-La Roche 40
Testing effectiveness (Phase 2)Study completedNCT00000921
What this trial is testing

The Effects of Prednisone on HIV Levels and the Immune System

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 118
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation